VDR and neoplasm: We demonstrate that calcipotriol stimulates the release of PGE2 both in PBMC and keratinocytes, which is in agreement with the following studies [55,56,73] and further supports the involvement of VDR/PGE2 signaling in drug-induced skin toxicity, as proposed by Shah et al. [56].